|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Coxsackie B Virus Antibodies
Test Code59117
CPT Codes
86658 (x6)
Preferred Specimen
1 mL serum
Minimum Volume
0.3 mL
Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum to an plastic transport tube.
Parallel testing is preferred, and convalescent specimens must be received within 30 days from receipt of acute specimens.
Parallel testing is preferred, and convalescent specimens must be received within 30 days from receipt of acute specimens.
Transport Container
Plastic transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 48 hours
Refrigerated: 14 days
Frozen: 1 year
Refrigerated: 14 days
Frozen: 1 year
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
CSF or plasma • Contaminated, hemolyzed, or severely lipemic specimens
Methodology
Semi-Quantitative Serum Neutralization
Setup Schedule
Set up: Mon-Fri; Report available: 6-12 days
Reference Range
Coxsackie B1: Less than 1:10
Coxsackie B2: Less than 1:10
Coxsackie B3: Less than 1:10
Coxsackie B4: Less than 1:10
Coxsackie B5: Less than 1:10
Coxsackie B6: Less than 1:10
Coxsackie B2: Less than 1:10
Coxsackie B3: Less than 1:10
Coxsackie B4: Less than 1:10
Coxsackie B5: Less than 1:10
Coxsackie B6: Less than 1:10
Clinical Significance
PCR testing is preferred for diagnosis of acute infection. Detect neutralizing antibodies to coxsackie B virus.
